NCT04521686 2025-06-27Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT01604863 2012-11-01A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid MalignanciesGlaxoSmithKlinePhase 1 Suspended54 enrolled